Stanford Drugs Surpasses 1 Million COVID-19 PCR Exams: Report

Stanford Drugs Surpasses 1 Million COVID-19 PCR Exams: Report

PALO ALTO, CA — Stanford Drugs reached a milestone earlier this month by processing its 1 millionth COVID-19 PCR take a look at.

That included 20,000 checks in seven days throughout the top of the current omicron surge, in accordance with a Stanford Information article. In whole, it’s taken practically 80,000 hours of labor for a laboratory group to work by way of the checks

“Laboratory employees have labored extremely onerous all through the pandemic,” mentioned Benjamin Pinsky, medical director of the scientific virology laboratory, mentioned to Stanford Information. “The calls for of the previous two years have been relentless, however they’ve been so resilient and decided to ship the well timed outcomes wanted to appropriately look after our sufferers whereas additionally defending these caring for them. They’re the actual stars of this story.”

Stanford Drugs was among the many first tutorial medical facilities to obtain FDA authorization for its PCR take a look at. It was initially supposed for use solely by Stanford’s hospital sufferers, however was shortly expanded because the virus continued to unfold.

The preliminary group of 20 laboratory staffers quickly expanded to 60 individuals, with around-the-clock protection.

“This milestone represents a variety of blood, sweat and tears,” mentioned Jennifer Fralick, administrative director of laboratory providers, within the article.

Click on right here to learn extra in Stanford Information.

This text initially appeared on the Palo Alto Patch

Read Also:  Physicians Are Getting the Improper Dose of Drugs